Terms: = Thyroid cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Treatment
7191 results:
1. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
Zhao H; Kang W; Guan J; Wang Y
Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
[TBL] [Abstract] [Full Text] [Related]
2. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
Park J; An S; Bae JS; Kim JS; Kim K
Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
[TBL] [Abstract] [Full Text] [Related]
3. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
[TBL] [Abstract] [Full Text] [Related]
4. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
[TBL] [Abstract] [Full Text] [Related]
5. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
6. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
7. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
[TBL] [Abstract] [Full Text] [Related]
8. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of endoscopic thyroidectomy via the oral vestibule approach and the areola approach for papillary thyroid carcinoma.
Liu Y; Lin F; Yan W; Lin E; Kuang P; Hong X; Lu Y; Wu G; Li L
BMC Surg; 2024 Apr; 24(1):127. PubMed ID: 38678205
[TBL] [Abstract] [Full Text] [Related]
10. Promising Approaches in Plant-Based Therapies for thyroid cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies.
Kaczmarzyk I; Nowak-Perlak M; Woźniak M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674046
[TBL] [Abstract] [Full Text] [Related]
11. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract] [Full Text] [Related]
12. Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
Fugazzola L; Deandrea M; Borgato S; Dell'Acqua M; Retta F; Mormile A; Carzaniga C; Gazzano G; Pogliaghi G; Muzza M; Persani L
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657647
[TBL] [Abstract] [Full Text] [Related]
13. Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study.
van Kinschot CMJ; Oudijk L; van Noord C; Korevaar TIM; van Nederveen FH; Peeters RP; van Kemenade FJ; Visser WE
Eur J Endocrinol; 2024 May; 190(5):374-381. PubMed ID: 38652802
[TBL] [Abstract] [Full Text] [Related]
14. PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
Kuboki Y; Koyama T; Matsubara N; Naito Y; Kondo S; Harano K; Yonemori K; Yoh K; Gu Y; Mita T; Chen X; Ueda E; Yamamoto N; Doi T; Shimizu T
Cancer Med; 2024 Apr; 13(8):e6980. PubMed ID: 38651187
[TBL] [Abstract] [Full Text] [Related]
15. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
[TBL] [Abstract] [Full Text] [Related]
16. Prevalence and impact of endocrine disorders in advanced metastatic cancer patients undergoing cancer-directed therapy: A prospective observational study.
Karna G; Sehrawat A; Karna S; Kant R; Sundriyal D; Karn S; Jha D
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2011. PubMed ID: 38644759
[TBL] [Abstract] [Full Text] [Related]
17. thyroid nodule rupture after radiofrequency ablation: case report and literature review.
Ferraro T; Sajid S; Hodak SP; Baldwin CK
Front Endocrinol (Lausanne); 2024; 15():1355383. PubMed ID: 38628591
[TBL] [Abstract] [Full Text] [Related]
18. The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview study.
D'souza B; Glover A; Bavor C; Brown B; Dodd RH; Lee JC; Millar J; Miller JA; Zalcberg JR; Serpell J; Ioannou LJ; Nickel B
BMJ Open; 2024 Apr; 14(4):e069236. PubMed ID: 38626980
[TBL] [Abstract] [Full Text] [Related]
19. Long-Term Follow-up of Patients With Autonomous thyroid Nodules Treated With Radioiodine.
Moroto D; Torquato-Vieira ICO; Fiorin LB; Camacho CP; Castiglioni MLV; Maciel RMB; Furlanetto RP; Matsumura LK; Janovsky CCPS; Lindsey SC; Martins JRM
Clin Nucl Med; 2024 Jun; 49(6):529-535. PubMed ID: 38619976
[TBL] [Abstract] [Full Text] [Related]
20. Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Wang Z; Zong H; Liu W; Lin W; Sun A; Ding Z; Chen X; Wan X; Liu Y; Hu Z; Zhang H; Li H; Liu Y; Li D; Zhang S; Zha X
J Exp Clin Cancer Res; 2024 Apr; 43(1):112. PubMed ID: 38610018
[TBL] [Abstract] [Full Text] [Related]
[Next]